
MRTNZ Investment Office · S&P 500 · The 360 Vantage
STE · NYSE
STERIS plc (Ireland) Ordinary Shares
Health Care · Industrial Specialties
Reference price$230.34As of Jul 28, 2026
Street view
Analyst targets
Published sell-side aggregation—not an MRTNZ forecast.
Forward calendar
Current earnings expectations
Consensus may change until the company reports.
Mar 2027$11.18Street EPS consensus
Mar 2028$11.94Street EPS consensus
Mar 2029$12.34Street EPS consensus
Reported results
Annual financial snapshot
Fiscal period ended Mar 31, 2026.
MetricCurrentPrior
Revenue+8.7% YoY$5.94B$5.46B
Operating income$1.1B$0.87B
Net income$0.78B$0.61B
Operating cash flow$1.34B$1.15B
Capital expenditures($0.37B)($0.37B)
Current context
Related news
Company-linked articles surfaced by Nasdaq.
Evidence
Sources & method
Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →
Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.